Who
Dyaarl Lee Anderson Jr.
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Sera Prognostics.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $26K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 23 Jun 2025
- Last trade
- 10 Sep 2026
- Last filed
- 11 Sep 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 11 Sep 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $3,6001,800 at $2.00 | filing |
| 10 Sep 2026filed 11 Sep 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $3,6001,800 at $2.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $9,5254,739 at $2.01 | filing |
| 11 Jun 2026filed 15 Jun 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $9,5254,739 at $2.01 | filing |
| 29 May 2026filed 1 Jun 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | $5,8293,168 at $1.84 | filing |
| 29 May 2026filed 1 Jun 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | $5,8293,168 at $1.84 | filing |
| 12 Mar 2026filed 13 Mar 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | —12,455 at $0.00 | filing |
| 12 Mar 2026filed 13 Mar 2026 | SERA Sera Prognosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —19,310 at $0.00 | filing |
| 12 Mar 2026filed 13 Mar 2026 | SERA Sera Prognosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —19,310 at $0.00 | filing |
| 12 Mar 2026filed 13 Mar 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | —12,455 at $0.00 | filing |
| 23 Jun 2025filed 23 Jun 2025 | SERA Sera Prognosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —102,534 at $0.00 | filing |
| 23 Jun 2025filed 23 Jun 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | —67,114 at $0.00 | filing |
News
Reviewing Black Diamond Therapeutics (NASDAQ:BDTX) & Sera Prognostics (NASDAQ:SERA)SERA · tickerreport.com · 22 Oct 2026Head to Head Survey: Immunocore (NASDAQ:IMCR) and Sera Prognostics (NASDAQ:SERA)SERA · dailypolitical.com · 20 Oct 2026Arrowhead Pharmaceuticals (NASDAQ:ARWR) versus Sera Prognostics (NASDAQ:SERA) Head to Head ReviewSERA · themarketsdaily.com · 18 Oct 2026
0 headlines in the last 90 days name Dyaarl Lee Anderson Jr.; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.